Cumberland Pharma more than doubles on FDA nod for pain reliever

Cumberland Pharmaceuticals

30/11/2021 10:44

** Drugmaker's  CPIX.O  shares jump over twofold premarket
after U.S. Food and Drug Administration (FDA) approves Caldolor,
its non-narcotic pain reliever, for pre-operative administration
    ** The product may now be administered just before surgery
to allow patients to wake up from the procedure in significantly
less pain, CPIX says
    ** Earlier this month, CPIX reported Q3 loss of 7 cents per
share  urn:newsml:reuters.com:*:nPn7SBtBZa
    ** In June, co said five case studies showed effectiveness
of its Vibativ drug in treating hospital-acquired and
ventilator-associated bacterial pneumonia in COVID-19 patients
    ** YTD, shares down ~25%

 (Reporting by Anisha Sircar in Bengaluru)
 ((Anisha.Sircar@thomsonreuters.com;))